Antibodies
22 April 2010
Genentech Submits Supplemental Application to FDA for Herceptin in Advanced HER2-Positive Stomach Cancer22 April 2010
Amylin, Lilly and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON(TM)21 April 2010
Genmab Announces Pipeline and Technology Update21 April 2010
Seattle Genetics and Agensys, an Affiliate of Astellas, Report ASG-5ME Preclinical Data at AACR21 April 2010
AVEO Pharmaceuticals’ Selective Anti-Notch1 Monoclonal Antibody Exhibits Potent Notch1 Inhibitory Activity20 April 2010
Phase III study evaluating ocrelizumab in patients with rheumatoid arthritis meets primary endpoint20 April 2010
Seattle Genetics to Receive $9.5 Million Payment from Genentech to Extend Antibody-Drug Conjugate Collaboration19 April 2010
GlaxoSmithKline receives conditional marketing authorisation in the EU for Arzerra (ofatumumab)19 April 2010
Immunomedics Develops Novel Immunoconjugate for Targeted Delivery of siRNAs to Solid Cancers15 April 2010
Kenta Biotech Reports 100% Survival with Panobacumab in Life-Threatening Hospital-Acquired Pneumonia15 April 2010
Circadians VGX-100 Significantly Inhibits Tumour Growth in Animal Models of Human Cancer14 April 2010
AVEO Pharmaceuticals Receives Milestone Payment from Biogen Idec under Licensing Agreement for ErbB3 Antibody Program1 April 2010
Symphogen Announces Initiation of Phase 1/2 Trial of Sym004 in Patients with Advanced Solid Tumors in the US30 March 2010
Lpath Completes Successful Phase I Study With ASONEP in Cancer Patients and Achieves $2 Million Merck KGaA Milestone29 March 2010
Erbitux Granted extended Use in Japan for First-Line-Treatment for mCRC-Patients with KRAS wild-type TumorsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports